Coya Therapeutics Inc. (COYA)
5.68
0.03 (0.53%)
At close: Jan 15, 2025, 3:59 PM
5.58
-1.76%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -7.99M | -12.24M | -4.89M | -733.20K |
| Depreciation & Amortization | 27.36K | 27.36K | 16.13K | n/a |
| Stock-Based Compensation | 872.25K | 207.35K | 233.22K | n/a |
| Other Working Capital | -4.94M | -93.45K | 74.00K | -27.27K |
| Other Non-Cash Items | 543.19K | 4.02M | -399.68K | 158.76K |
| Deferred Income Tax | n/a | n/a | 399.68K | n/a |
| Change in Working Capital | -4.64M | 751.84K | 739.17K | 77.95K |
| Operating Cash Flow | -11.19M | -7.24M | -3.90M | -391.27K |
| Capital Expenditures | n/a | n/a | -136.80K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -543.19K | -525.00K | n/a | n/a |
| Investing Cash Flow | -543.19K | -525.00K | -136.80K | n/a |
| Debt Repayment | n/a | 10.47M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 89.95K | -1.11M | -340.58K | 9.11M |
| Financial Cash Flow | 38.43M | 9.36M | -340.58K | 9.11M |
| Net Cash Flow | 26.69M | 1.59M | -4.38M | 8.72M |
| Free Cash Flow | -11.19M | -7.24M | -4.04M | -391.27K |